Delivra Health Brands Inc.
DHBUF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $5,823 | $9,764 | $3,746 | $6,406 |
| - Cash | $2,425 | $4,200 | $2,721 | $1,084 |
| + Debt | $2,113 | $2,027 | $1,957 | $2,107 |
| Enterprise Value | $5,511 | $7,591 | $2,982 | $7,429 |
| Revenue | $13,370 | $12,378 | $9,791 | $8,139 |
| % Growth | 8% | 26.4% | 20.3% | – |
| Gross Profit | $6,778 | $6,399 | $4,823 | $2,604 |
| % Margin | 50.7% | 51.7% | 49.3% | 32% |
| EBITDA | $144 | $2,354 | $1,396 | -$4,255 |
| % Margin | 1.1% | 19% | 14.3% | -52.3% |
| Net Income | -$874 | $876 | -$184 | -$7,009 |
| % Margin | -6.5% | 7.1% | -1.9% | -86.1% |
| EPS Diluted | -0.028 | 0.031 | -0.007 | -0.28 |
| % Growth | -191.2% | 520.5% | 97.4% | – |
| Operating Cash Flow | -$554 | $756 | -$1,088 | -$4,441 |
| Capital Expenditures | $0 | $0 | -$41 | -$22 |
| Free Cash Flow | -$554 | $756 | -$1,129 | -$4,463 |